About: Increased in-hospital mortality from COVID-19 in patients with schizophrenia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Increased in-hospital mortality from COVID-19 in patients with schizophrenia Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Increased in-hospital mortality from COVID-19 in patients with schizophrenia
Creator	Jimeno, Marie-Thérèse Leone, Marc Antonini, François Auquier, Pascal Boyer, Laurent Fabre, Cyprien Fond, Guillaume François, Msc Klay, Sophie Lancon, Christophe Md, Antonini Msc, Klay Orleans, Veronica Pauly, Vanessa Sanz, Michel Sophie, Msc
source	Elsevier; PMC
abstract	Abstract Background: There is limited information describing the presenting characteristics and outcomes of patients with schizophrenia (SCZ) requiring hospitalization for coronavirus disease 2019 (COVID-19). Aims: We aimed to compare the clinical characteristics and outcomes of COVID-19 SCZ patients with those of non-SCZ patients. Method: This was a case-control study of COVID-19 patients admitted to 4 APHM/AMU acute care hospitals in Marseille, southern France. COVID-19 infection was confirmed by a positive result on polymerase chain reaction testing of a nasopharyngeal sample and/or on chest computed scan among patients requiring hospital admission. The primary outcome was in-hospital mortality. The secondary outcome was intensive care unit (ICU) admission. Results: A total of 1092 patients were included. The overall in-hospital mortality rate was 9.0%. The SCZ patients had an increased mortality compared to the non-SCZ patients (26.7% vs. 8.7%, p=0.039), which was confirmed by the multivariable analysis after adjustment for age, sex, smoking status, obesity and comorbidity (adjusted odds ratio 4.36 [95% CI 1.09-17.44]; p=0.038). In contrast, the SCZ patients were not more frequently admitted to the ICU than the non-SCZ patients. Importantly, the SCZ patients were mostly institutionalized (63.6%, 100% of those who died), and they were more likely to have cancers and respiratory comorbidities. Conclusions: This study suggests that SCZ is not overrepresented among COVID-19 hospitalized patients, but SCZ is associated with excess COVID-19 mortality, confirming the existence of health disparities described in other somatic diseases.
has issue date	2020-07-30(xsd:dateTime)
bibo:doi	10.1016/j.encep.2020.07.003
has license	els-covid
sha1sum (hex)	b3654582539ca50a6967bafdd7d8ba2c50960408
schema:url	https://doi.org/10.1016/j.encep.2020.07.003
resource representing a document's title	Increased in-hospital mortality from COVID-19 in patients with schizophrenia
has PubMed Central identifier	PMC7392112
schema:publication	Encephale
resource representing a document's body	covid:b3654582539ca50a6967bafdd7d8ba2c50960408#body_text
is schema:about of	named entity 'PAS' named entity 'liens' named entity 'SCZ' named entity 'mechanical ventilation' named entity 'medical record' named entity 'hospital care' named entity 'Respiratory rate' named entity 'auteurs' named entity 'SCZ' named entity 'COVID-19' named entity 'Normandy' named entity 'COVID' named entity 'SCZ' named entity 'infection' named entity 'comorbidities' named entity 'SCZ' named entity 'ICD10' named entity 'coronavirus' named entity 'AMU' named entity 'health disparities' named entity 'France' named entity 'COVID' named entity 'Charlson comorbidity index' named entity 'general population' named entity 'homelessness' named entity 'SAPS II' named entity 'hydroxychloroquine' named entity 'mortality' named entity 'COVID' named entity 'COVID' named entity 'China' named entity 'French Ministry of Health' named entity 'COVID' named entity 'COVID' named entity 'COVID' named entity 'COVID-19' named entity 'general population' named entity 'acute care' named entity 'median age' named entity 'SCZ' named entity 'SCZ' named entity 'SCZ' named entity 'SCZ' named entity 'social distancing' named entity 'COVID' named entity 'general population' named entity 'co-morbidities' named entity 'Charlson comorbidity index' named entity 'Mann-Whitney' named entity 'general population' named entity 'SCZ' named entity 'SCZ' named entity 'pulmonary embolism' named entity 'missing data' named entity 'comorbidities' named entity 'infection' named entity 'SCZ' named entity 'SCZ' named entity 'ICU' named entity 'COVID-19' named entity 'mental disorder' named entity 'electronic health records' named entity 'schizophrenia' named entity 'Corsica' named entity 'negative symptoms' named entity 'ICU' named entity 'China' named entity 'obesity'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software